Study of Osteoporosis in chronic obstructive pulmonary disease

EL-Gazzar, Ahmad Godah; Abdalla, Mohamed E.; Almahdy, Mohamed A.

doi:10.1016/j.ejcdt.2013.01.009

Cited by 10 publications

(10 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This result was almost similar to the study of Jorgensen et al 18 that the mean age of the male COPD patients was 62.8 ± 5.6 years. This result also correlated with other studies 5,20 .…”

Section: Discussionsupporting

confidence: 81%

See 1 more Smart Citation

Prevalence of Osteoporosis in Male Patients with Chronic Obstructive Pulmonary Disease

Bari

Patwary²,

Hossain

et al. 2018

Med. Today

View full text Add to dashboard Cite

show abstract

“…This result was almost similar to the study of Jorgensen et al 18 that the mean age of the male COPD patients was 62.8 ± 5.6 years. This result also correlated with other studies 5,20 .…”

Section: Discussionsupporting

confidence: 81%

“…In men with COPD, osteoporosis may be particularly disabling because vertebral fractures reduce vital capacity, which further compromises ventilation 18 . Evidence suggests that the prevalence of osteoporosis in patients with COPD is high and potentially important 19,20 .…”

Section: Discussionmentioning

confidence: 99%

Prevalence of Osteoporosis in Male Patients with Chronic Obstructive Pulmonary Disease

Bari

Patwary²,

Hossain

et al. 2018

Med. Today

View full text Add to dashboard Cite

show abstract

“…These results were in agreement with those of Mansour O F et al 27 These results can be explained as increase in COPD degree is associated with increase of risk factors that lead to occurrence of osteoporosis such as increased inflammatory load of COPD, using more corticosteroid treatment, decrease in pulmonary functions, and decrease in BMI. 37 Sin et al 38 , also revealed that the risk for osteopenia increases by 30% in patients with moderate COPD and by 70% in those with severe COPD and the risk for osteoporosis increases by 2.1-fold in moderate COPD and by 2.8-fold in severe COPD, compared with normal individuals.…”

Section: Discussionmentioning

confidence: 93%

Osteoporosis among the Chronic Obstructive Pulmonary Disease Patients

Rashid¹,

Chowdhury²,

Amin³

et al. 2020

Anwer Khan Mod Med Coll J

View full text Add to dashboard Cite

Background: COPD is a widely prevalent disease with high morbidity and mortality and is associated with various comorbidities, among which is osteoporosis. However, osteoporosis is often undiagnosed in these patients. Material and methods: This study was conducted on 40 patients with COPD and 15 healthy controls (the control group). They were selected from EMCH from Jan 2015 to Dec 2017. All participants were subjected to detailed clinical history taking, a thorough clinical examination, plain chest radiography (posteroanterior and lateral views), blood sampling for complete blood picture, erythrocyte sedimentation rate, and serum calcium and phosphates, ventilatory function tests (spirometry), and measurement of bone density using dual-energy X-ray absorptiometry (DEXA). Results: The results of this study revealed prevalence of osteoporosis was higher in the COPD group compared with the control group (P < 0.00). Prevalence of osteoporosis increased with increasing severity of COPD (P < 0.00). Conclusion: Osteopenia and osteoporosis are more prevalent in COPD patients than in healthy controls and the severity of osteoporosis increases with increasing severity of COPD. Anwer Khan Modern Medical College Journal Vol. 11, No. 1: Jan 2020, P 16-21

show abstract

“…Abu-Bakr et al in a study on 60 male subjects reported an increased prevalence of low BMD (56.6%) among men with COPD (Gold stage III-IV) than healthy individuals of same age and sex. They noted a threefold increase in fracture risk in COPD patients with low BMD than COPD patients with normal BMD [16]. Another study by A. Godah EL-Gazzar et al demonstrated abnormal BMD in 80% of the COPD patients of moderate to the very severe stage.…”

Section: Prevalence Of Low Bmd In Copdmentioning

confidence: 92%

A Review of Reduced Bone Health in Chronic Obstructive Pulmonary Disease Patients

Akshayadas¹

2017

WJPR

View full text Add to dashboard Cite

The chronic obstructive pulmonary disease is a progressive inflammatory disease of the airways with high morbidity and mortality worldwide. COPD is associated with various comorbidities of which osteoporosis is a significant one. Reduced bone health (osteoporosis or/and osteopenia) is very common in COPD patients and has a significant impact on morbidity, mortality and economic burden.However such reduced bone health is often undiagnosed in COPD patients. Decreased bone mineral density and bone quality contribute to fragility fractures that worsen the respiratory function and further reduce the quality of life of the COPD patients. Routine screening of bone health enables the physician to identify osteoporosis and osteopenia at an early stage and can reduce the chance of osteoporotic fractures. Thus management of comorbidities should be incorporated into the management of COPD which will improve the outcome in COPD patients. Various risk factors, such as tobacco smoking, older age, low physical activity, vitamin D deficiency, low Body Mass Index (BMI) and use of oral or inhaled corticosteroids are considered to be responsible for osteoporosis or/and osteopenia in COPD patients. This review focuses on the prevalence of reduced bone health in COPD patients and some of the risk factors involved in the development of such reduced bone health.

show abstract

Study of Osteoporosis in chronic obstructive pulmonary disease

Cited by 10 publications

References 18 publications

Prevalence of Osteoporosis in Male Patients with Chronic Obstructive Pulmonary Disease

Prevalence of Osteoporosis in Male Patients with Chronic Obstructive Pulmonary Disease

Osteoporosis among the Chronic Obstructive Pulmonary Disease Patients

A Review of Reduced Bone Health in Chronic Obstructive Pulmonary Disease Patients

Contact Info

Product

Resources

About